Garivulimab, CAS 2342597-81-1

Product Description: Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity[1].

Applications: Cancer-programmed cell death

Formula: N/A

CAS Number: 2342597-81-1

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Apoptosis;PD-1/PD-L1

• Artikelnummer: MEXHY-P99633-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99633-5
• Verpackungseinheit: 5mg
• Mengeneinheit: STK
• Konjugat: Unconjugated